Alameda County plans to give away 15 million free diapers
A program in Alameda County will help parents get diapers and wipes for free.On Monday, the county launched one of the largest diaper bank programs in the country. It's part of a $5.8 million three-year program to provide families free diapers and wipes.
The National Diaper Bank Network releases an annual report called the Diaper Check. In 2024, they found diapers cost more than $100 a month, and 46% of families with young children reported diaper insecurity.
The groups behind the diaper bank said diaper insecurity can lead to health problems, with desperate parents leaving them on for too long. They said, in California, there are approximately 40,000 preventable visits to the emergency room every year for rashes, infections and severe diaper rash.
"Emergency rooms and urgent care are not the solution to diaper need," said Supervisor Lena Tam, who chairs the Social Services Committee on the Board of Supervisors. "Research shows that one of the most effective means of addressing diaper need is to integrate diaper and wipe distribution into existing wraparound services provided by trusted local partners. This is why I am proud of our County and our partners' collective leadership expanding one of the largest diaper bank programs in the Country to 50 sites across our county. No family should have to experience the harmful consequences of diaper need."
The initiative is funded by Alameda County and First 5 Alameda. It will be run by the Alameda County Social Services Agency and the nonprofit SupplyBank.org.
Parents will be able to get free diapers and wipes from 50 sites placed at libraries, WIC centers, schools, health clinics, and community-based organizations. The goal is to distribute more than 15 million diapers and 37 million baby wipes.
See the list of distribution sites here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
43 minutes ago
- Associated Press
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated withbenign prostatic hyperplasiaor BPH—a condition affecting millions of men1—and encourages them to take control of their health. The Teleflex Prostate Education Express, a mobile training and education center, is on a national tour to educate physicians and the community on prostate health quality-of-life issues associated with BPH and the importance of organ spacing to protect against potential rectal side effects in advance of prostate cancer radiation treatment. WAYNE, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced two bold awareness initiatives in conjunction with Men's Health Month to raise awareness for quality-of-life issues associated with benign prostatic hyperplasia ('BPH') and the potential rectal toxicity side effects for men who undergo a prostate cancer radiation treatment plan. The initiative includes a new ad campaign featuring the Prostate Monster, and a mobile training and education center—The Prostate Education Express—which is visiting urology practices, hospitals and academic medical centers across major U.S. cities for the remainder of 2025. These activities are focused on educating physicians and the community on the benefits of treatment with the UroLift™ System, the #1 chosen minimally invasive, outpatient treatment for symptoms of an enlarged prostate, or BPH1, and the benefits of organ spacing using the Barrigel™ rectal spacer in advance of prostate cancer radiation therapy.2 The ad campaign airing on cable networks, streaming platforms, and related digital ads, features the unforgettable 'Prostate Monster,' a larger-than-life symbol of the everyday disruption BPH can cause in men's lives—from interfering with sleep to making simple tasks like mowing the lawn or sitting in traffic uncomfortable. The ads direct viewers to where men can learn more and take the first step toward relief. When the prostate grows, it can press against the urethra and block the flow of urine, leading to symptoms like frequent urination, weak stream, and interrupted sleep.3 More than 500,000 men have been treated with the UroLift™ System in select markets worldwide.4 Despite how common BPH is, many men delay treatment. 'So many men suffer silently with symptoms that can seriously affect their quality of life,' said Claus Roehrborn, M.D* professor of urology at UT Southwestern Medical Center and primary investigator on many UroLift™ System clinical studies over the past 12 years. 'Men need to know they don't have to 'just deal with it.' The UroLift™ System offers rapid symptom relief without the need for ongoing medications.'5,6 As a traveling classroom, training hub, and community engagement center, the Prostate Education Express provides hands-on UroLift™ System and Barrigel™ rectal spacer simulator training at a practice's front door. The national tour will support training for general practicing physicians. The truck will also host community health talks to educate men about their prostate health and collaborate with advocacy events to amplify BPH awareness across major U.S. cities including New York City, Los Angeles, Chicago, Houston, Dallas, Atlanta, Miami, Washington, DC, San Francisco, and Philadelphia. 'June is Men's Health Month—a time to shine the spotlight on the unique health challenges men face, including BPH, a non-cancerous progressive health concern that commonly occurs as men age,' said Anthony Parrillo, vice president, Global Marketing, Teleflex Interventional Urology. 'Across the U.S., 14.1 million men seek treatment for BPH symptoms annually.1 The national ad and Prostate Education Express initiatives are extensions of our mission to empower the future of healthcare by educating and motivating men to prioritize their prostate health and seek out effective, proven treatment options like the UroLift™ System5 and understand the importance of rectal organ protection in advance of prostate cancer radiation treatment with Barrigel™ rectal spacer2.' A clinical study found that 98.5 percent of men who were treated with Barrigel™ rectal spacer met the primary endpoint of achieving at least a 25 percent reduction in radiation to the rectum.2 Patients who met the primary endpoint averaged an 85 percent reduction in radiation to the rectum, and Barrigel™ rectal spacer is proven superior in the reduction of acute and long-term Grade 2+ GI toxicity at 3 and 6 months compared to control.2 More than 50,000 men have been treated with Barrigel™ rectal spacer, the first and only hyaluronic acid rectal spacer.2,7,8,9,10 For more information about the UroLift™ System, visit About the UroLift™ System The UroLift™ System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It is indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older (50 years outside U.S.). The UroLift™ System permanent implants, which can be delivered during an outpatient procedure,11 relieve prostate obstruction without heating, cutting, destruction of, or removing prostate tissue. The UroLift™ System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.12 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.**13-14 A study conducted over 5 years showed a low retreatment rate of about 2-3% per year, or a total of 13.6 percent over the course of the study, demonstrating UroLift™ System durability.5 Most common side effects are temporary and can include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence.6 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Individual results may vary. The prostatic urethral lift procedure (using the UroLift™ System) is recommended for the treatment of BPH in both the 2021 American Urological Association and 2022 European Association of Urology clinical guidelines. More than 500,000 men have been treated with the UroLift™ System in select markets worldwide.4 Learn more at Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. About Barrigel™ Rectal Spacer Barrigel™ rectal spacer is the first and only hyaluronic acid rectal spacer that separates the prostate from the rectum to protect the rectum during radiation therapy treatment for prostate cancer.2 Barrigel™ rectal spacer is made from Non-Animal Stabilized Hyaluronic Acid (NASHA).16 Hyaluronic acid is a substance naturally present in the human body and is highly biocompatible and fully absorbable. NASHA has a proven history of safety and efficacy in a wide variety of medical applications in men, women and children worldwide.15,17 Barrigel™ rectal spacer has been proven to significantly reduce unwanted side effects from prostate cancer radiation therapy2 and is cleared for rectal spacing in the United States, Australia, and Europe.18 Barrigel™ rectal spacer is indicated for prostate cancer patients with T1-T3b disease. For more information about Barrigel™ rectal spacer, please visit Barrigel™ Rectal Spacer Important Safety Information Barrigel™ rectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and, in creating this space, it is the intent of Barrigel™ rectal spacer to reduce the radiation dose delivered to the anterior rectum. Barrigel™ rectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is intended to be absorbed by the patient's body over time. Barrigel™ rectal spacer should only be administered by qualified and properly trained physicians with experience in ultrasound guidance and injection techniques in the urogenital/pelvic area. As with any medical treatment, there are some risks involved with the use of Barrigel™ rectal spacer. Potential complications associated with the use of Barrigel™ rectal spacer include, but are not limited to: pain associated with Barrigel™ rectal spacer injection; needle penetration of the bladder, prostate, rectal wall, rectum, or urethra; injection of Barrigel™ rectal spacer into the bladder, prostate, rectal wall, rectum, urethra, or intravascularly; local inflammatory reactions; infection; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; constipation; and rectal urgency. More information on indications, contraindications, warnings and instructions for use can be found in the Instructions For Use at Individual results may vary. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. About Teleflex Incorporated As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose. At Teleflex, we are empowering the future of healthcare. For more information, please visit Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. Teleflex, the Teleflex logo, Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are the property of their respective owners. © 2025 Teleflex Incorporated. All rights reserved. References *Paid consultants of Teleflex. **No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study †Study sponsored by Palette Life Sciences, now part of Teleflex. MAC03104-01 Rev A Contacts: Teleflex Lawrence Keusch Vice President, Investor Relations and Strategy Development [email protected] 610-948-2836 Media Contact: Glenn Silver Partner National Media Relations Specialist
WIRED
an hour ago
- WIRED
The Best Organic Mattress Toppers for Your Nontoxic Bed
WIRED TIRED Available in extra firm No trial period Full organic certifications Cover sold separately Provides excellent support and cushioning PlushBed's 3-inch topper is the extra firm topper I always dreamed of when trapped in the horrors of hotel memory foam mattresses. Now, to be fair to PlushBed, this latex topper doesn't have to be extra firm. PlushBed offers five firmness levels ranging from 'soft' to 'extra firm.' I went for extra firm and could not be happier. It's the firmest topper or mattress I've ever tried. It's so firm I used the 3-inch model by itself for a bed in our vintage RV. Again, though, if you want something softer, PlushBed has you covered. PlushBed's latex topper is made of GOLS-certified Talalay latex. It also carries the Oeko-Tex Standard 100 and Greenguard Gold certifications, meaning there should be no fillers, chemical dyes, pesticides, bleach, carcinogenic adhesives, chemical flame retardants, or other toxins. As with the Turmerry above, the cover is sold separately, and again, I don't think it's really necessary. I will say that the queen-size 3-inch extra firm version I tested is by far the heaviest topper I've used, and can be difficult to maneuver into place. The good news is, once you have it where you want it, there's no danger of it moving. Prices range from $288 for a twin 2-inch soft topper to $974 for a 3-inch extra firm California king topper. Specs Composition GOLS-certified Talalay latex Firmness Soft, medium-soft, medium, medium-firm, extra-firm Height 2, 3 inches Cover Sold separately Trial period None WIRED TIRED Dunlop and Talalay latex versions available Probably too firm for side sleepers Excellent breathability Good amount of contouring to relieve pressure points Avocado's Eco Mattress Topper is its cheapest mattress topper, but certainly doesn't feel like it. This latex topper is incredibly light and springy, making even my super-firm mattress feel soft and contouring without that strange sinking sensation you can get on other soft mattress toppers. There are two feel options, Medium and Plush, both of which use different types of latex. I tested the Medium, which still gave me plenty of softness, and the GOLS-certified (Global Organic Latex Standard) organic Dunlop latex was very airy to sleep on. The Plush version uses Talalay Latex, which generally offers a softer feel and more breathability, making for slightly cooler sleeping. Both feature a GOTS-certified organic cotton cover with a hidden underside zipper. — Nena Farrell Prices range from $199 for a twin to $399 for a California king. Specs Composition GOLS-certified Dunlop latex or FSC certified Talalay latex. GOTS-certified organic cotton cover Firmness Medium, Plush Height 2, 3 inches Cover Not removable or washable Trial period 100 nights
Fox News
an hour ago
- Fox News
GOP lawmaker grills ex-CEO over 23andMe pronouns post, forcing her to admit she doesn't know what they mean
Rep. Brandon Gill, R-Texas, grilled 23andMe co-founder and former CEO Anne Wojcicki on Tuesday about a social media post regarding transgender pronouns, forcing her to admit she is not "up to speed" about what they mean. Lawmakers are in the process of launching an investigation to assess the risk of 23andMe users' genetic data being transferred to third party buyers amid the company's bankruptcy. Wojcicki testified before a U.S. House committee a few months after she stepped down as CEO of the genetics analysis company in March. While the hearing was focused on data privacy as the company potentially changes hands, Gill questioned the former CEO about a politically-charged post the company's official X account made under her watch. "23andMe has really, over the past few years, gone out of its way to show how woke it is. And one of the things that it's been promoting, among many others, is a variety of different pronouns," he said as he shared a Pride month post from 2021. "Science shows using correct pronouns can impact trans people's health by significantly reducing their risk of depression and suicide. This is one of many reasons why we have been working to improve our product for trans and non-binary customers," the post said, along with a graphic showing 14 pronouns ranging from the standard "He, him, she, her," to the esoteric "ze, hir, xe, xem, fae, faer, e, em." The tweet linked to a 23andMe company blog post headlined, "Trust the Science by Supporting Trans Health Care." The piece said "medical experts" support allowing trans people to use the bathroom of their gender identity, and defended "Gender-affirming health care" for children by citing pediatric guidelines. Gill pressed the former CEO about the X post, noting one of the pronouns in particular, "I just wanna ask you, what does 'e' mean as a pronoun?" "To be honest, I am not sure," Wojcicki replied. "Okay, do you know what 'em' means as a pronoun?" Gill asked. "I'm also not sure," the former CEO replied. "Don't you think it's important to know what these mean? You guys are – In this post you wrote, or somebody in your comms team wrote, that using the correct pronouns impacts trans people's health and reduce the risk of depression and suicide," Gill said. "That's a pretty serious claim. It seems like if you're gonna demand people use these pronouns you would know what they mean, right?" "I was CEO, but that doesn't mean I can oversee every single post," Wojcicki said. "Very very politically charged post that you guys put out, I would think that you'd have a view on that," Gill said, going on to ask the former CEO the difference between the 'xe' and 'ze' pronouns. "I'm not up to speed on that," she replied. Grill pressed Wojcicki again on whether she felt like not understanding these pronouns indeed marginalizes transgender people, and she replied that she supports her research team who felt that it is important for the company "to be inclusive of everybody." Gill went on to argue that even if the social and research team had put out the messaging, she was CEO at the time, and cannot "pawn off responsibility to somebody else." Referring to the company blog post, he asked whether it had been 23andMe's policy to allow biological men to use the women's restroom while she was still the CEO. After noting the company had non-gendered bathrooms as well, Wojcicki answered that while she was CEO, "I think our position was just to make sure that we're applicable to laws." He then grilled her about the post mentioning support for transgender procedures for youth, and Wojcicki defended it by noting that it cited specific pediatric guidelines. "Sounds to me like you took a genetics company that you built - and congratulations for doing that - and turned it into a woke social justice organization," Gill said, claiming that she is now running from such a position now that such ideas have fallen from popularity.
